Creating a stronger, more diverse New York City life science ecosystem by funding underrepresented populations who look to bring promising translational research to patients.
Deerfield is a healthcare investment management firm committed to advancing healthcare through investment, information and philanthropy. For more information, please visit

Proposal Submission

2022/2023 Submission Cycle

2023 Submission Cycle
  • January 20 - Applications Due
  • February 13 - Finalists Notified
  • March 2 - Virtual Finalist Presentation
  • April 3 - In Person Award Ceremony

Click here to create a profile and apply to the 2022/2023 cycle.


2021-2022 Submission Cycle
Read More
2020-2021 Submission Cycle
Read More
Dr Amel Ibrahim, MBBS PhD MRCS

The Deerfield XSeed award has helped accelerate Bioworkshop’s progress in a way that’s hard to overstate. It has not only allowed us to showcase the versatility of our platform by developing a new model of the central nervous system and Parkinson’s disease but has also embedded us in Deerfield’s startup ecosystem. We’ve enjoyed access to networking events, seminars and support from their partners and contacts. As we’re approaching the next stage of our journey, commercialisation of our technology, I look forward to continuing to tap into the community for support and guidance as well as to contribute by mentoring the next generation of awardees.

Dr Amel Ibrahim, MBBS PhD MRCS
CEO & Founder, Bioworkshop


Claire Pomeroy

Nancy Thornberry

Jenny Laird

Elise Wang

Joseph Pearlberg

Hsueh-Cheng (H.C.) Huang


Deerfield Management Announces 2023 XSeed Award Winners

NEW YORK, April 3, 2023 — Deerfield Management Company, a healthcare investment firm and Advancium Health Network, a public charity dedicated to eliminating barriers to the advancement of healthcare, today announced the grant recipients and winners of the third annual XSeed Award. The winners will each receive a $250,000 grant to support business growth. Founded in 2019, The XSeed Award supports women- and minority-led life science startups in New York City to help address critical funding gaps and bridge promising translational research to the marketplace and commercial success.

Deerfield Management Announces Third Annual XSeed Award to Support Underfunded and Underrepresented NYC Life Science Startups

NEW YORK, NEW YORK – Nov. 29, 2022 – Deerfield Management Company, a New York City-based healthcare investment firm and Advancium Health Network, a public charity dedicated to advancing healthcare services and health equity through philanthropic investment, announced today the third annual XSeed Award, a program designed to support early-stage life science, minority- and women-led startups in New York City. A change from previous award seasons, this year, two life science startup companies will each be awarded up to $250,000.

News Archives

Deerfield Management Announces XSeed Award Winners
Read More
Second Annual $500,000 XSeed Award Launched by Deerfield Management to Support Underfunded and Underrepresented NYC Life Science Startups
Read More
On April 20th 2021, the XSeed Winners were announced at “Deerfield Live at the Cure”.
Read More
Deerfield Launches a Novel Funding Mechanism, the X-Seed Award, to Support Early-Stage Life Sciences and Underrepresented Company Founders
Read More
Deerfield Management Announces Winners of the First Annual XSeed Award
Read More

Contact Us

Error sending form, please try again.